[HTML][HTML] Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)
F Patriarca, A Bacigalupo, A Sperotto, M Isola… - …, 2008 - haematologica.org
Background Allogeneic stem cell transplantation is a potentially curative treatment for
myelofibrosis, although its use is limited by a high rate of transplant-related mortality. In this …
myelofibrosis, although its use is limited by a high rate of transplant-related mortality. In this …
[PDF][PDF] Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)
F Patriarca, A Bacigalupo, A Sperotto, M Isola… - haematologica, 2008 - Citeseer
Background Allogeneic stem cell transplantation is a potentially curative treatment for
myelofibrosis, although its use is limited by a high rate of transplant-related mortality. In this …
myelofibrosis, although its use is limited by a high rate of transplant-related mortality. In this …
Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
F Patriarca, A Bacigalupo, A Sperotto, M Isola… - …, 2008 - iris.unisa.it
BACKGROUND: Allogeneic stem cell transplantation is a potentially curative treatment for
myelofibrosis, although its use is limited by a high rate of transplant-related mortality. In this …
myelofibrosis, although its use is limited by a high rate of transplant-related mortality. In this …
[引用][C] Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
F Patriarca, A Bacigalupo, A Sperotto, M Isola… - …, 2008 - flore.unifi.it
Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of
the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). IRIS IRIS Home Sfoglia Macrotipologie …
the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). IRIS IRIS Home Sfoglia Macrotipologie …
Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)”
F PATRIARCA, A BACIGALUPO, A SPEROTTO… - 2008 - ricerca.unityfvg.it
Background Allogeneic stem cell transplantation is a potentially curative treatment for
myelofibrosis, although its use is limited by a high rate of transplant-related mortality. In this …
myelofibrosis, although its use is limited by a high rate of transplant-related mortality. In this …
[引用][C] Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)
F PATRIARCA - Haematologica, 2008 - cir.nii.ac.jp
Allogeneic hematopoietic stem cell transplantation in myelofibrosis : the 20-year experience
of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO) | CiNii Research CiNii 国立情報学 …
of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO) | CiNii Research CiNii 国立情報学 …
[PDF][PDF] Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)
F Patriarca, A Bacigalupo, A Sperotto, M Isola… - haematologica, 2008 - core.ac.uk
Background Allogeneic stem cell transplantation is a potentially curative treatment for
myelofibrosis, although its use is limited by a high rate of transplant-related mortality. In this …
myelofibrosis, although its use is limited by a high rate of transplant-related mortality. In this …
Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)
F Patriarca, A Bacigalupo, A Sperotto… - …, 2008 - pubmed.ncbi.nlm.nih.gov
Background Allogeneic stem cell transplantation is a potentially curative treatment for
myelofibrosis, although its use is limited by a high rate of transplant-related mortality. In this …
myelofibrosis, although its use is limited by a high rate of transplant-related mortality. In this …
[HTML][HTML] Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)
F Patriarca, A Bacigalupo, A Sperotto, M Isola… - …, 2008 - haematologica.org
Background Allogeneic stem cell transplantation is a potentially curative treatment for
myelofibrosis, although its use is limited by a high rate of transplant-related mortality. In this …
myelofibrosis, although its use is limited by a high rate of transplant-related mortality. In this …
Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
F Patriarca, A Bacigalupo, A Sperotto, M Isola… - …, 2008 - europepmc.org
Background Allogeneic stem cell transplantation is a potentially curative treatment for
myelofibrosis, although its use is limited by a high rate of transplant-related mortality. In this …
myelofibrosis, although its use is limited by a high rate of transplant-related mortality. In this …